CHINA PHARMA HOLDINGS, INC. Proceeds from Short-term Debt
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Proceeds from Short-term Debt of -$4.52 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2018-04-02
- CHINA PHARMA HOLDINGS, INC. proceeds from short-term debt for the quarter ending 2016-12-31 was -$2.24M.
- CHINA PHARMA HOLDINGS, INC. proceeds from short-term debt for the quarter ending 2015-12-31 was $0.00.
- CHINA PHARMA HOLDINGS, INC. proceeds from short-term debt for fiscal 2016 was -$4.52M.
- CHINA PHARMA HOLDINGS, INC. proceeds from short-term debt for fiscal 2015 was $0.00.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 9 month | Proceeds from Short-term Debt 12 month |
|---|---|---|---|
| 2016-12-31 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$4.52M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$2.28M 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 10-K · filed 2017-03-31 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |